From Respiratory Therapist to PulmonaryTech Founder: How Breathing Experts Are Building Lung Health Startups

How respiratory therapists are building PulmonaryTech startups using pulmonary expertise. Discover remote spirometry, ventilator analytics, airway clearance devices, and respiratory telehealth startup opportunities.

By Vantage Research Team · 2026-03-23 · 11 min read

From Respiratory Therapist to PulmonaryTech Founder: How Breathing Specialists Are Building the Next Wave of Lung Health Startups

The global respiratory care market exceeds $30 billion and is projected to surpass $45 billion by 2030, driven by rising COPD prevalence, post-COVID pulmonary rehabilitation demand, sleep apnea diagnostics, and home-based respiratory monitoring. Yet the industry remains dependent on legacy devices, fragmented data systems, and manual patient management. Respiratory therapists who understand both the clinical science and operational bottlenecks are uniquely positioned to build the next generation of PulmonaryTech companies.

Why Respiratory Therapists Make Exceptional PulmonaryTech Founders

Ventilator and Device Expertise

RTs manage complex mechanical ventilation — setting and adjusting modes (AC, SIMV, PSV, APRV), interpreting waveforms, troubleshooting patient-ventilator asynchrony, and executing weaning protocols. This device-level expertise is irreplaceable when building AI-powered ventilator management tools, remote monitoring platforms, or next-generation respiratory devices.

Pulmonary Diagnostics Mastery

Respiratory therapists perform pulmonary function testing (spirometry, DLCO, lung volumes, bronchoprovocation), arterial blood gas analysis, and cardiopulmonary exercise testing. This diagnostic fluency enables building AI screening tools, home-based PFT devices, and clinical decision support systems that engineering-only teams cannot validate.

Cross-Setting Clinical Experience

RTs work across ICUs, emergency departments, neonatal units, pulmonary rehab clinics, sleep labs, and home care — giving them a panoramic view of respiratory care delivery. This cross-setting experience reveals system-level inefficiencies and interoperability gaps that create product opportunities.

High-Impact PulmonaryTech Startup Opportunities

1. Remote Respiratory Monitoring Platforms

Build IoT-enabled platforms that continuously monitor respiratory patients at home — tracking SpO2, respiratory rate, peak flow, symptom scores, and medication adherence. Current home respiratory monitoring is fragmented across disconnected devices with no unified dashboard for clinicians.

Revenue model: Per-patient monitoring fee ($30-80/month) billed to home health agencies or payers, or B2B SaaS to pulmonary practices at $500-2,000/month.

2. AI-Powered Ventilator Weaning Decision Support

Design clinical decision support tools that analyze ventilator waveforms, spontaneous breathing trial data, and patient trends to recommend optimal weaning strategies. Ventilator weaning is one of the highest-stakes clinical decisions in critical care, and premature or delayed extubation both carry significant risks.

Revenue model: Per-ICU-bed licensing at $200-500/month, or hospital-wide enterprise contracts.

3. Smart Inhaler and Medication Adherence Technology

Create connected inhaler devices or add-on sensors that track medication usage, technique quality, environmental triggers, and symptom patterns. Inhaler non-adherence rates exceed 50%, costing billions in preventable ED visits and hospitalizations.

Revenue model: Device sale ($30-80) plus app subscription ($5-15/month), or B2B licensing to pharmaceutical companies and payers.

4. Portable Pulmonary Function Testing Devices

Build smartphone-connected spirometry devices that deliver clinical-grade pulmonary function testing outside traditional PFT labs. Demand for accessible lung function screening has surged post-COVID, and current portable options lack the accuracy and clinical validation needed for diagnostic use.

Revenue model: Device sale ($200-500) plus per-test cloud interpretation fee ($5-15), or enterprise licensing to occupational health programs.

5. Sleep Apnea Screening and Management Platforms

Design AI-powered home sleep testing platforms that screen for obstructive sleep apnea, titrate CPAP therapy remotely, and track treatment adherence. An estimated 80% of moderate-to-severe OSA remains undiagnosed, representing massive unmet demand.

Revenue model: Per-patient screening fee ($50-150) or subscription management platform at $15-30/patient/month for DME companies and sleep clinics.

Building Your PulmonaryTech Startup

Start With Your Clinical Specialty

Your deepest clinical area is your strongest startup foundation. An ICU-focused RT should build critical care tools, while a home care RT should focus on remote monitoring. Your subspecialty knowledge ensures product-clinical fit that generalist teams cannot achieve.

Validate With Pulmonologists and Hospital Buyers

RTs have direct working relationships with pulmonologists, intensivists, and hospital administrators. These relationships provide immediate access to clinical validation partners and early adopters. Use your existing network to validate before building.

Address the Data Interoperability Gap

Respiratory care data is siloed across ventilators, monitors, EMRs, and home devices. Any platform that unifies respiratory data into actionable clinical intelligence solves a problem every pulmonary care team experiences daily.

Market Timing

The convergence of post-COVID respiratory awareness, home-based care expansion, wearable sensor maturity, and AI clinical decision support creates an unprecedented window for PulmonaryTech innovation. Respiratory therapists who combine device expertise with clinical workflow knowledge will build companies that transform how respiratory diseases are monitored, managed, and treated.

Ready to discover which PulmonaryTech startup ideas match your respiratory therapy expertise? Start your free Vantage interview →

← Back to all articles

Start Your Free AI Interview